Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Speaking at a conference in Dubrovnik, Bank of England policymaker Megan Greene said tokenised deposits - digital forms of traditional bank balances - may supplant stablecoins within years. Greene argued commercial banks will move to develop digital deposit products once they recognize the risk of losing fees and deposits, while some colleagues, in…
Viking is trading at fresh 52-week highs after a sustained recovery in travel demand and strong premium pricing. Fundamentals and technicals line up for further upside, but fuel costs, competitive entry into river cruising and elevated valuation warrant a disciplined entry and a defined stop. This trade proposes a long with an entry near the market…
Comfort Systems USA (FIX) has rallied into a consolidation phase after a blistering multi-year move driven by data-center HVAC demand. The company brings a $12.45 billion backlog, strong margins, and $1.38B in free cash flow to the table. Valuation is rich but supported by growth and a fortress balance sheet. This trade idea targets a mid-term rebo…
Two separate opinion polls published on Sunday show right-wing candidate Keiko Fujimori narrowly leading leftist Roberto Sanchez ahead of Peru's presidential runoff scheduled for June 7. Ipsos indicated 38% for Fujimori and 35% for Sanchez, while Datum Internacional recorded 39.8% and 35.9% respectively. Both surveys highlight a significant share o…
Cotality reported that Australian home prices were broadly flat in May as higher borrowing costs and recent tax reforms targeting property investors weakened buyer demand across most major cities. Sydney and Melbourne led declines, while Perth and Darwin posted the strongest gains. Rents continued to climb, with annual national rent growth hitting …
A new annual survey from Colonial First State finds Australians now reckon they need more than A$1 million ($718,450) to retire comfortably, an increase of A$183,000 in the past year. Inflation and rising living costs are cited as key reasons for concern, with many expecting to work longer than their ideal retirement age and women reporting higher …
More than 200 people were injured and one person died after celebrations for Paris Saint-Germain's successive Champions League title turned violent in Paris and other French cities. Authorities reported 57 police officers hurt, over 400 arrests and scattered vandalism, while Interior Minister Laurent Nunez described a major security operation that …
Federal Reserve Governor Christopher Waller warned that broad adoption of stablecoins globally could effectively export U.S. monetary conditions to jurisdictions that use them. He repeated earlier support for stablecoins paired with clear regulation, and criticized central bank digital currencies (CBDCs) as an unnecessary fix. Meanwhile, the Europe…
Alamos Gold (AGI) offers leveraged exposure to rising gold prices through stable production and growth optionality at high-grade assets. This trade idea establishes a defined-entry long with a clear stop and two staged targets keyed to a constructive near-term gold outlook and execution catalysts.
Bank of America reiterated a Buy rating on Meta Platforms and upheld an $835 price target, pointing to nascent signs of AI monetization and corporate uptake as potential catalysts for sentiment after months of investor concern over rising AI-related expenditures. The bank highlighted Meta’s paid AI subscription rollout and a new Enterprise Solution…
Kimbell Royalty Partners reported stronger-than-expected Q1 production, declared a $0.41 distribution, and is evaluating M&A while keeping net debt to EBITDA at ~1.6x. The recent Permian acquisition modestly increases oil exposure; the combination of an ~11% yield, steady free cash flow, and active acreage makes KRP a tactical swing buy. Entry $15.…
Canadian Solar is transitioning from a module-first company to a hybrid developer-manufacturer where battery energy storage systems (BESS) are driving better economics. The market is still pricing execution risk aggressively: market cap is $1.29B, price-to-book sits at 0.45 and the stock trades well below its 52-week high. For traders willing to ac…
Silicom (SILC) has already seen the boom-and-bust typical of networking-cycle names. Price action, technicals and short-volume behaviour suggest the market is still valuing a re-acceleration that hasn't materialized. For traders, that creates a defined mid-term short opportunity: entry near today's levels, a nearby stop above last week's swing high…
Repligen (RGEN) is showing a technical and fundamental recovery as bioprocessing demand accelerates, but the stock trades at premium multiples (P/E ~136, P/S ~9.2) that leave little margin for execution missteps. This is a swing trade idea: enter near current levels, limit downside with a firm stop, and take profits into a near-term catalyst window…
Vicor's mid-quarter guidance raise and Q1 metrics (revenue $113M, 55.2% gross margins, $301M backlog) crystallize an IP-driven, high-margin growth story exposed to AI and data-center spend. The stock is richly valued but momentum, backlog and licensing cash flow create a favorable risk/reward for a mid-term swing. Enter with a clear stop and define…
U.S. equities have extended gains as technology shares rally on AI-driven profit forecasts, but a June jobs report and recent inflation readings raise concerns that higher interest rates and increasing Treasury yields could unsettle the advance. Semiconductor heavyweight Broadcom's quarterly results will also be watched for signs that the red-hot A…
Immatics N.V. presented extended Phase 1 data for its TCR bispecific candidate IMA401 targeting MAGEA4/8 in heavily pretreated solid tumor patients, showing favorable tolerability and encouraging anti-tumor activity across multiple indications including head and neck cancer, melanoma, and lung cancer. The data supports combining IMA401 with IMA402 …
Microsoft's share price reflects expectations of perpetual multiple expansion and flawless AI monetization. We see a near-term pullback risk driven by stretched sentiment and limited incremental margin upside. Here is a mid-term short trade with clear entry, stop and target, plus catalysts and risk controls.
Saudi Arabia's equity market finished Sunday in positive territory, with the Tadawul All Share index rising 0.46% at the close. Gains were concentrated in Hotels & Tourism, Industrial Investment and Insurance sectors, while crude oil prices declined and gold futures advanced. Market breadth favored advancers over decliners by a wide margin.
Intellia has been grinding forward: clinical holds lifted, fresh capital on the balance sheet, and improving technicals. With market cap under $2.0B and $1.76B in cash, a binary path to first commercial approval creates asymmetry for a mid-term swing trade. This idea lays out an entry, stop, targets, and the risks to watch.
MasterBrand completed the $3.6B acquisition of American Woodmark on 05/29/2026. The combined company trades at just ~0.41x price-to-sales and an EV/EBITDA around 11.4x today. With solid liquidity (current ratio 2.08), moderate leverage (debt/equity 0.82) and free cash flow generation, this setup offers a constructive risk-reward for a long trade si…
A late-stage trial presented at the American Society of Clinical Oncology found that adding Johnson & Johnson’s Erleada (apalutamide) to standard testosterone-blocking hormone therapy before and after prostate removal surgery greatly increased the chance of minimal residual disease at surgery and reduced the risk of cancer spread or death. The stud…
Revolution Medicines announced positive topline results from its pivotal Phase 3 RASolute 302 trial showing daraxonrasib significantly improves overall survival and progression-free survival compared to chemotherapy in previously treated metastatic pancreatic ductal adenocarcinoma (PDAC). The trial met all primary and key secondary endpoints with a…
Immunocore Holdings plc reported updated Phase 1/2 data for brenetafusp monotherapy in heavily pretreated HLA-A*02:01-positive advanced melanoma patients, achieving a 6-month overall survival rate of 87% and disease control rate of 52%. The data support selecting a 160 mcg dose for the ongoing Phase 3 PRISM-MEL-301 trial in first-line advanced mela…
Replimune Group, Inc. presented final first-in-human Phase 1 data for its investigational oncolytic immunotherapy RP2, both as monotherapy and in combination with nivolumab, in heavily pretreated patients with advanced solid tumors. The therapy showed an objective response rate around 19%, durable responses, and evidence of systemic immune activati…
